Compare BCRX & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | PRVA |
|---|---|---|
| Founded | 1986 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.7B |
| IPO Year | 1995 | 2021 |
| Metric | BCRX | PRVA |
|---|---|---|
| Price | $8.37 | $21.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $20.82 | ★ $31.17 |
| AVG Volume (30 Days) | ★ 4.4M | 803.1K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | 63.64 |
| EPS | N/A | ★ 0.02 |
| Revenue | $25,186,000.00 | ★ $2,122,842,000.00 |
| Revenue This Year | N/A | $18.19 |
| Revenue Next Year | $12.55 | $10.72 |
| P/E Ratio | ★ N/A | $1,081.50 |
| Revenue Growth | N/A | ★ 22.26 |
| 52 Week Low | $6.00 | $18.78 |
| 52 Week High | $11.22 | $26.51 |
| Indicator | BCRX | PRVA |
|---|---|---|
| Relative Strength Index (RSI) | 42.68 | 43.14 |
| Support Level | $8.13 | $21.20 |
| Resistance Level | $8.68 | $24.09 |
| Average True Range (ATR) | 0.33 | 0.60 |
| MACD | -0.04 | -0.13 |
| Stochastic Oscillator | 25.21 | 35.83 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.